Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2011-08-30
2011-08-30
Spivack, Phyllis G. (Department: 1629)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
Reexamination Certificate
active
08008349
ABSTRACT:
The invention relates to a pharmaceutical preparation comprising levothyroxine sodium, gelatine and fillers, which is free of organic solvent residues.
REFERENCES:
patent: 3621098 (1971-11-01), Prange et al.
patent: 3808332 (1974-04-01), Reynolds
patent: 5225204 (1993-07-01), Papadimitrou et al.
patent: 5955105 (1999-09-01), Mitra et al.
patent: 6491946 (2002-12-01), Schreder et al.
patent: 2005/0003491 (2005-01-01), Jacobs et al.
patent: 195 41 128 (1997-04-01), None
patent: 1180574 (1970-02-01), None
patent: 1296510 (1972-11-01), None
patent: WO 93/04691 (1993-03-01), None
Remington's Pharmaceutical Sciences (15th edition), Mack Publishing Company, PA (1975), p. 1578.
Kokil et al., AAPS PharmSciTech (2004), 5(3), pp. 1-5.
Derwent World Patent Index AN 97-527238 & CN 1 126 589 (Jul. 17, 1996).
Nischwitz Marion
Schreder Sven
Merck Patent GmbH
Millen White Zelano & Branigan P.C.
Spivack Phyllis G.
LandOfFree
Stable pharmaceutical preparation comprising levothyroxine... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stable pharmaceutical preparation comprising levothyroxine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable pharmaceutical preparation comprising levothyroxine... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2757545